文献速递肝病消化道肿瘤与早癌

2型糖尿病病程与非酒精性脂肪性肝病肝脏相关事件:里程碑分析

Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis.
PubMed 文献 · Hepatology · 2023-05-01

本研究为香港全地区队列研究,纳入2000年1月1日至2021年7月31日诊断的成人非酒精性脂肪性肝病(NAFLD)患者,采用里程碑分析在生物年龄40、50、60、70岁评估2型糖尿病(T2D)病程与肝脏相关事件及全因死亡的关系。以60岁无糖尿病者为参照,T2D病程<5年、6-10年、>10年者的肝脏相关事件调整亚分布风险比(SHR)分别为2.51、3.16、6.20。结论认为T2D病程越长,NAFLD患者肝脏相关事件和全因死亡风险越高。

要点

  • 以60岁无糖尿病者为参照,T2D病程<5年、6-10年、>10年者肝脏相关事件调整SHR分别为2.51、3.16、6.20。
  • T2D病程与全因死亡之间也观察到类似的关联。
  • NAFLD患者中,T2D病程越长,肝脏相关事件和全因死亡风险越高。

核心结论

  • 在NAFLD患者中,较长的T2D病程与肝脏相关事件和全因死亡风险升高显著相关。

研究设计与样本

  • 香港全地区队列研究,纳入2000年1月1日至2021年7月31日诊断的成人NAFLD患者。
  • T2D定义为使用任何降糖药、实验室检查和/或诊断编码。
  • 主要终点为肝脏相关事件,即肝细胞癌与肝硬化并发症的复合终点。
  • 采用里程碑分析,在生物年龄40、50、60、70岁四个年龄点评估T2D病程。

主要发现

  • 以60岁无糖尿病者为参照(肝脏相关事件发生率0.70/1000人年),T2D病程<5年者调整SHR为2.51(95%CI:1.32-4.77;发生率2.26/1000人年)。
  • 以60岁无糖尿病者为参照,T2D病程6-10年者调整SHR为3.16(95%CI:1.59-6.31;发生率2.54/1000人年)。
  • 以60岁无糖尿病者为参照,T2D病程>10年者调整SHR为6.20(95%CI:2.62-14.65;发生率4.17/1000人年)。
  • T2D病程与全因死亡之间也观察到类似的关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: We aimed to determine the impact of the duration of type 2 diabetes (T2D) on the risk of liver-related events and all-cause mortality in patients with NAFLD. APPROACH AND RESULTS: We conducted a territory-wide cohort study of adult patients with NAFLD diagnosed between January 1, 2000, and July 31, 2021, in Hong Kong. T2D was defined by the use of any antidiabetic agents, laboratory tests, and/or diagnosis codes. The primary endpoint was liver-related events, defined as a composite endpoint of HCC and cirrhotic complications. To conduct a more granular assessment of the duration of T2D, we employed landmark analysis in four different ages of interest (biological age of 40, 50, 60, and 70 years). By multivariable analysis with adjustment of non-liver-related deaths, compared with patients without diabetes at age 60 (incidence rate of liver-related events: 0.70 per 1,000 person-years), the adjusted subdistribution HR (SHR) of liver-related events was 2.51 (95% CI: 1.32-4.77; incidence rate: 2.26 per 1,000 person-years) in patients with T2D duration < 5 years, 3.16 (95% CI: 1.59-6.31; incidence rate: 2.54 per 1,000 person-years) in those with T2D duration of 6-10 years, and 6.20 (95% CI: 2.62-14.65; incidence rate: 4.17 per 1000 person-years) in those with T2D duration more than 10 years. A similar association between the duration of T2D and all-cause mortality was also observed. CONCLUSIONS: Longer duration of T2D is significantly associated with a higher risk of liver-related events and all-cause mortality in patients with NAFLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Zhang X, Yip TC, Tse YK, et al. Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis. Hepatology. 2023. PMID: 37119179. doi:10.1097/HEP.0000000000000432

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。